C5a, a therapeutic target in sepsis.

Recent patents on anti-infective drug discovery

Volumn 1, Issue 1, 2006, Pages 57-65

  Guo, Ren Feng ^a   Ward, Peter A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR;

ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; MORTALITY; MULTIPLE ORGAN FAILURE; NEUTROPHIL; PATENT; REVIEW; SEPSIS; SURVIVAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANIMALS; COMPLEMENT C5A; HUMANS; MULTIPLE ORGAN FAILURE; NEUTROPHILS; PATENTS AS TOPIC; RECEPTOR, ANAPHYLATOXIN C5A; SEPSIS; SURVIVAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 34547903734     PISSN: 1574891X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157489106775244091     Document Type: Review

References (74)